Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology.
The myelodysplastic syndromes (MDS) comprise a heterogeneous group of clonal disorders of the haematopoietic stem cell and primarily involve cells of the myeloid lineage. Using cDNA microarrays comprising 6000 human genes, we studied the gene expression profiles in the neutrophils of 21 MDS patients...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2004
|
| _version_ | 1826273860806246400 |
|---|---|
| author | Pellagatti, A Esoof, N Watkins, F Langford, C Vetrie, D Campbell, L Fidler, C Cavenagh, J Eagleton, H Gordon, P Woodcock, B Pushkaran, B Kwan, M Wainscoat, J Boultwood, J |
| author_facet | Pellagatti, A Esoof, N Watkins, F Langford, C Vetrie, D Campbell, L Fidler, C Cavenagh, J Eagleton, H Gordon, P Woodcock, B Pushkaran, B Kwan, M Wainscoat, J Boultwood, J |
| author_sort | Pellagatti, A |
| collection | OXFORD |
| description | The myelodysplastic syndromes (MDS) comprise a heterogeneous group of clonal disorders of the haematopoietic stem cell and primarily involve cells of the myeloid lineage. Using cDNA microarrays comprising 6000 human genes, we studied the gene expression profiles in the neutrophils of 21 MDS patients, seven of which had the 5q- syndrome, and two acute myeloid leukaemia (AML) patients when compared with the neutrophils from pooled healthy controls. Data analysis showed a high level of heterogeneity of gene expression between MDS patients, most probably reflecting the underlying karyotypic and genetic heterogeneity. Nevertheless, several genes were commonly up or down-regulated in MDS. The most up-regulated genes included RAB20, ARG1, ZNF183 and ACPL. The RAB20 gene is a member of the Ras gene superfamily and ARG1 promotes cellular proliferation. The most down-regulated genes include COX2, CD18, FOS and IL7R. COX2 is anti-apoptotic and promotes cell survival. Many genes were identified that are differentially expressed in the different MDS subtypes and AML. A subset of genes was able to discriminate patients with the 5q- syndrome from patients with refractory anaemia and a normal karyotype. The microarray expression results for several genes were confirmed by real-time quantitative polymerase chain reaction. The MDS-specific expression changes identified are likely to be biologically important in the pathophysiology of this disorder. |
| first_indexed | 2024-03-06T22:34:39Z |
| format | Journal article |
| id | oxford-uuid:59777661-451b-4786-bf94-6ceddd14591c |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T22:34:39Z |
| publishDate | 2004 |
| record_format | dspace |
| spelling | oxford-uuid:59777661-451b-4786-bf94-6ceddd14591c2022-03-26T17:09:56ZGene expression profiling in the myelodysplastic syndromes using cDNA microarray technology.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:59777661-451b-4786-bf94-6ceddd14591cEnglishSymplectic Elements at Oxford2004Pellagatti, AEsoof, NWatkins, FLangford, CVetrie, DCampbell, LFidler, CCavenagh, JEagleton, HGordon, PWoodcock, BPushkaran, BKwan, MWainscoat, JBoultwood, JThe myelodysplastic syndromes (MDS) comprise a heterogeneous group of clonal disorders of the haematopoietic stem cell and primarily involve cells of the myeloid lineage. Using cDNA microarrays comprising 6000 human genes, we studied the gene expression profiles in the neutrophils of 21 MDS patients, seven of which had the 5q- syndrome, and two acute myeloid leukaemia (AML) patients when compared with the neutrophils from pooled healthy controls. Data analysis showed a high level of heterogeneity of gene expression between MDS patients, most probably reflecting the underlying karyotypic and genetic heterogeneity. Nevertheless, several genes were commonly up or down-regulated in MDS. The most up-regulated genes included RAB20, ARG1, ZNF183 and ACPL. The RAB20 gene is a member of the Ras gene superfamily and ARG1 promotes cellular proliferation. The most down-regulated genes include COX2, CD18, FOS and IL7R. COX2 is anti-apoptotic and promotes cell survival. Many genes were identified that are differentially expressed in the different MDS subtypes and AML. A subset of genes was able to discriminate patients with the 5q- syndrome from patients with refractory anaemia and a normal karyotype. The microarray expression results for several genes were confirmed by real-time quantitative polymerase chain reaction. The MDS-specific expression changes identified are likely to be biologically important in the pathophysiology of this disorder. |
| spellingShingle | Pellagatti, A Esoof, N Watkins, F Langford, C Vetrie, D Campbell, L Fidler, C Cavenagh, J Eagleton, H Gordon, P Woodcock, B Pushkaran, B Kwan, M Wainscoat, J Boultwood, J Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology. |
| title | Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology. |
| title_full | Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology. |
| title_fullStr | Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology. |
| title_full_unstemmed | Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology. |
| title_short | Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology. |
| title_sort | gene expression profiling in the myelodysplastic syndromes using cdna microarray technology |
| work_keys_str_mv | AT pellagattia geneexpressionprofilinginthemyelodysplasticsyndromesusingcdnamicroarraytechnology AT esoofn geneexpressionprofilinginthemyelodysplasticsyndromesusingcdnamicroarraytechnology AT watkinsf geneexpressionprofilinginthemyelodysplasticsyndromesusingcdnamicroarraytechnology AT langfordc geneexpressionprofilinginthemyelodysplasticsyndromesusingcdnamicroarraytechnology AT vetried geneexpressionprofilinginthemyelodysplasticsyndromesusingcdnamicroarraytechnology AT campbelll geneexpressionprofilinginthemyelodysplasticsyndromesusingcdnamicroarraytechnology AT fidlerc geneexpressionprofilinginthemyelodysplasticsyndromesusingcdnamicroarraytechnology AT cavenaghj geneexpressionprofilinginthemyelodysplasticsyndromesusingcdnamicroarraytechnology AT eagletonh geneexpressionprofilinginthemyelodysplasticsyndromesusingcdnamicroarraytechnology AT gordonp geneexpressionprofilinginthemyelodysplasticsyndromesusingcdnamicroarraytechnology AT woodcockb geneexpressionprofilinginthemyelodysplasticsyndromesusingcdnamicroarraytechnology AT pushkaranb geneexpressionprofilinginthemyelodysplasticsyndromesusingcdnamicroarraytechnology AT kwanm geneexpressionprofilinginthemyelodysplasticsyndromesusingcdnamicroarraytechnology AT wainscoatj geneexpressionprofilinginthemyelodysplasticsyndromesusingcdnamicroarraytechnology AT boultwoodj geneexpressionprofilinginthemyelodysplasticsyndromesusingcdnamicroarraytechnology |